TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Neurotrauma Research Sweden Nrs AB
Closing information (x1000 NOK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
491
|
500
|
647 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-134
|
-189
|
4,954 |
| EBITDA |
-107
|
-160
|
339 |
| Total assets |
7,297
|
7,750
|
7,310 |
| Current assets |
116
|
363
|
518 |
| Current liabilities |
325
|
220
|
31 |
| Equity capital |
6,973
|
7,530
|
7,279 |
| - share capital |
101
|
104
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
95.6%
|
97.2%
|
99.6% |
| Turnover per employee |
491
|
500
|
647 |
| Profit as a percentage of turnover |
-27.3%
|
-37.8%
|
765.7% |
| Return on assets (ROA) |
-1.8%
|
-2.4%
|
67.8% |
| Current ratio |
35.7%
|
165.0%
|
1671.0% |
| Return on equity (ROE) |
-1.9%
|
-2.5%
|
68.1% |
| Change turnover |
6
|
-204
|
-95 |
| Change turnover % |
1%
|
-29%
|
-13% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.